FDA — authorised 10 November 1983
- Application: NDA018768
- Marketing authorisation holder: CORDEN PHARMA
- Local brand name: VEPESID
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Oral Etoposide on 10 November 1983
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 10 November 1983; FDA has authorised it.
CORDEN PHARMA holds the US marketing authorisation.